Method for constructing novel bacterium belonging to the genus bifidobacterium
一种双歧杆菌属、制作方法的技术,应用在新型双歧杆菌属细菌的制作领域,能够解决低通用性、不能适用、不能发挥存活性改善效果等问题,达到存活性高、利用性高的效果
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1)
[0076] (Example 1) Breeding improvement of Bifidobacterium breve YIT 10001 and YIT4125 obtained by alternate subculture
[0077] Bifidobacterium breve strain YIT 10001 (FERM BP-8205) and Bifidobacterium breve strain YIT4125 (FERM BP-7813) were used as parent strains for alternate passage and enrichment.
[0078] (1) Sterilize 20.7% whole milk powder medium at 135°C for 3.5 seconds, and then inoculate 0.5% seed starter of Bifidobacterium breve YIT 10001 strain or YIT 4125 strain, 1% Bifidobacterium breve The inoculum of bifidobacteria was mixed and cultured at 33°C until the pH was 5.3, and the bacterial solution A1 (400mL) was prepared.
[0079] (2) Blend syrup A into bacterial solution A1 so that the final concentration of palatinose is 10%, and prepare dairy product A1 (630 mL). Divide dairy product A1 (200mL) into 300mL flasks, stir (90rpm) at 5°C for 1 week under aerobic conditions with cotton plugs placed, store (hereinafter referred to as aerobic stirring storage), and ...
Embodiment 2)
[0085] (Example 2) Viability confirmation test
[0086] Using the parent strain and the isolated strain, prepare dairy products A and B respectively according to the method in Example 1, store them under aerobic conditions at 5°C with stirring for 1 week, and then store them statically at 10°C under anaerobic conditions for 2 weeks . Bifidobacterium breve YIT 12272 strain (from YIT 4125, isolated from dairy product A8) with good survival in both dairy products A and B was selected.
[0087] Table 3 shows the results of viability in dairy products A and B of YIT 12272 strain and control bacteria (YIT 10001 strain, YIT 4125 strain). Regardless of whether YIT 12272 strains were stored in either dairy products A or B, 3×10 7 Viable bacteria above CFU / mL. On the other hand, any one of the dairy products A and B made with the control bacteria left 3×10 7 Live bacteria above CFU / mL, but the products of the two cannot show good viability.
[0088] In addition, the physical proper...
Embodiment 3)
[0098] (Example 3) Confirmation test of artificial gastric juice tolerance
[0099] Bifidobacterium breve YIT 12272 strain and control bacteria (YIT 10001 strain, YIT 4125 strain) were anaerobically cultured in milk medium at 37°C overnight. Add 0.5 mL of this bacteria solution to 10 mL of artificial gastric juice warmed at 37°C for 30 minutes, mix quickly, and then keep warm at 37°C. After incubation (artificial gastric juice treatment) for 0 minutes and 120 minutes, 1 mL was aliquoted, and after appropriate dilution, the number of viable bacteria was measured in TOS propionate agar medium (Yakult Pharmaceutical Industry, 37°C, anaerobic culture).
[0100] Among them, the artificial gastric juice was prepared as follows. That is, dissolve in ion-exchanged water so that the final concentration is peptone (Becton, Dickinson and Co.): 5 g / L, gastric mucosin (Wako Pure Chemical Industries): 1.5 g / L, sodium chloride: 5 g / L, Sodium bicarbonate: 3g / L, sodium dihydrogen phosphate: ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com